a:4:{s:3:"url";s:129:"https://www.commondreams.org/news/2022/11/18/patients-push-biden-hhs-act-pharma-firm-charges-190k-lifesaving-prostate-cancer-drug";s:9:"image_url";s:159:"https://www.commondreams.org/sites/default/files/styles/social_share_image/public/2022-11/Lower-Drug-Prices-GettyImages-1431083022.jpg?h=217a038c&itok=Ftg87m_2";s:5:"title";s:95:"Patients Push Biden HHS to Act as Pharma Firm Charges $190K for Lifesaving Prostate Cancer Drug";s:11:"description";s:272:"&#34;Cancer does not wait, nor should cancer patients have to wait for years for their government to act,&#34; health access advocates assert in a letter asking HHS to invoke &#34;march-in rights&#34; to secure lower prices for the $190,000/yr prostate cancer drug Xtandi.";}